Encompass Health Co. (NYSE:EHC) Stake Reduced by GSA Capital Partners LLP

GSA Capital Partners LLP lessened its stake in shares of Encompass Health Co. (NYSE:EHC) by 61.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,525 shares of the company’s stock after selling 5,703 shares during the period. GSA Capital Partners LLP’s holdings in Encompass Health were worth $341,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. UMB Bank n.a. increased its holdings in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after purchasing an additional 252 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% in the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock valued at $39,000 after purchasing an additional 140 shares during the period. Oakworth Capital Inc. acquired a new position in shares of Encompass Health in the 2nd quarter valued at about $40,000. Benjamin F. Edwards & Company Inc. increased its holdings in shares of Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after purchasing an additional 198 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Encompass Health in the 2nd quarter valued at about $58,000. Institutional investors and hedge funds own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on EHC. KeyCorp increased their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Barclays increased their price target on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada increased their target price on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Nine investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $107.11.

Encompass Health Stock Performance

Encompass Health stock opened at $101.14 on Friday. The company has a market cap of $10.19 billion, a PE ratio of 24.43, a PEG ratio of 1.31 and a beta of 0.88. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. Encompass Health Co. has a 1 year low of $63.78 and a 1 year high of $104.55. The company’s 50-day moving average is $97.11 and its two-hundred day moving average is $90.81.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter in the prior year, the company posted $0.86 earnings per share. The firm’s revenue was up 11.9% on a year-over-year basis. Equities analysts anticipate that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Thursday, January 2nd. Encompass Health’s dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.